Report Detail

Bioelectric medicines, also known as electroceuticals, are medical devices that are used to restore health in patients. Bioelectric medicines function through neurostimulation and modulation of the nervous systems through electrical impulses. Global bioelectric medicine market will reach $39.06 billion by 2030, growing by 6.4% annually over 2020-2030 driven by growing geriatric population and rising acceptance of bioelectric medicines.
Highlighted with 71 tables and 76 figures, this 169-page report “Global Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global bioelectric medicine market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global bioelectric medicine market in every aspect of the classification from perspectives of Product Type, End User, and Region.

Based on Product Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Implantable Bioelectric Medicine
• Cardiac Pacemaker
• Implantable Cardioverter Defibrillators (ICD)
• Spinal Cord Stimulators (split into Chronic Pain, Failed Back Syndrome (FBSS), Ischemia by application)
• Cochlear Implants
• Deep Brain Stimulators (split into Parkinson’s Disease, Tremor, Depression, Other Deep Brain Stimulation Applications by application)
• Vagus Nerve Stimulators
• Sacral Nerve Stimulators (split into Urinary Incontinence and Fecal Incontinence by application)
• Retinal Implants
• Other Implantable Bioelectric Medicines
Non-invasive Bioelectric Medicine
• Transcutaneous Electrical Nerve Stimulators
• Transcranial Magnetic Stimulation (TMS)
• Pulsed Electromagnetic Field Therapy
• Other Non-invasive Bioelectric Medicines

Based on End User, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Hospitals and Clinics
• Research Institutes
• Individual Users

Geographically, the following regions together with the listed national/local markets are fully investigated:
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
• North America (U.S., Canada, and Mexico)
• South America (Brazil, Chile, Argentina, Rest of South America)
• RoW (Saudi Arabia, UAE, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Product Type and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in global bioelectric medicine market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Cochlear Limited
electroCore, Inc.
Inspire Medical Systems, Inc.
LivaNova PLC
Medtronic PLC
NeuroMetrix, Inc
Nevro Corp.
Nuvectra Corporation
OMRON CORPORATION
Pixium Vision
Second Sight Medical Products Inc
SetPoint Medical
Sonova Holding AG
St. Jude Medical, Inc.
Stimwave LLC
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)


1 Introduction 8

  • 1.1 Industry Definition and Research Scope 8
    • 1.1.1 Industry Definition 8
    • 1.1.2 Research Scope 9
  • 1.2 Research Methodology 12
    • 1.2.1 Overview of Market Research Methodology 12
    • 1.2.2 Market Assumption 13
    • 1.2.3 Secondary Data 13
    • 1.2.4 Primary Data 13
    • 1.2.5 Data Filtration and Model Design 15
    • 1.2.6 Market Size/Share Estimation 16
    • 1.2.7 Research Limitations 17
  • 1.3 Executive Summary 18

2 Market Overview and Dynamics 20

  • 2.1 Market Size and Forecast 20
    • 2.1.1 Impact of COVID-19 on the Market 21
  • 2.2 Major Growth Drivers 23
  • 2.3 Market Restraints and Challenges 27
  • 2.4 Emerging Opportunities and Market Trends 30
  • 2.5 Porter’s Fiver Forces Analysis 34

3 Segmentation of Global Market by Product Type 38

  • 3.1 Market Overview by Product Type 38
  • 3.2 Implantable Bioelectric Medicine 40
    • 3.2.1 Cardiac Pacemaker 42
    • 3.2.2 Implantable Cardioverter Defibrillators (ICD) 43
    • 3.2.3 Spinal Cord Stimulators 44
    • 3.2.4 Cochlear Implants 45
    • 3.2.5 Deep Brain Stimulators 46
    • 3.2.6 Vagus Nerve Stimulators 47
    • 3.2.7 Sacral Nerve Stimulators 48
    • 3.2.8 Retinal Implants 49
    • 3.2.9 Other Implantable Bioelectric Medicines 50
  • 3.3 Non-invasive Bioelectric Medicine 51
    • 3.3.1 Transcutaneous Electrical Nerve Stimulators 53
    • 3.3.2 Transcranial Magnetic Stimulation (TMS) 54
    • 3.3.3 Pulsed Electromagnetic Field Therapy 55
    • 3.3.4 Other Non-invasive Bioelectric Medicines 56

4 Segmentation of Global Market by End User 57

  • 4.1 Market Overview by End User 57
  • 4.2 Hospitals and Clinics 59
  • 4.3 Research Institutes 60
  • 4.4 Individual Users 61

5 Segmentation of Global Market by Region 62

  • 5.1 Geographic Market Overview 2019-2030 62
  • 5.2 North America Market 2019-2030 by Country 68
    • 5.2.1 Overview of North America Market 68
    • 5.2.2 U.S. 72
    • 5.2.3 Canada 78
    • 5.2.4 Mexico 80
  • 5.3 European Market 2019-2030 by Country 82
    • 5.3.1 Overview of European Market 82
    • 5.3.2 Germany 86
    • 5.3.3 UK 88
    • 5.3.4 France 90
    • 5.3.5 Spain 92
    • 5.3.6 Italy 94
    • 5.3.7 Russia 96
    • 5.3.8 Rest of European Market 98
  • 5.4 Asia-Pacific Market 2019-2030 by Country 100
    • 5.4.1 Overview of Asia-Pacific Market 100
    • 5.4.2 Japan 104
    • 5.4.3 China 107
    • 5.4.4 Australia 109
    • 5.4.5 India 111
    • 5.4.6 South Korea 113
    • 5.4.7 Rest of APAC Region 115
  • 5.5 South America Market 2019-2030 by Country 117
    • 5.5.1 Argentina 120
    • 5.5.2 Brazil 122
    • 5.5.3 Chile 124
    • 5.5.4 Rest of South America Market 126
  • 5.6 MEA Market 2019-2030 by Country 127
    • 5.6.1 UAE 130
    • 5.6.2 Saudi Arabia 132
    • 5.6.3 South Africa 134
    • 5.6.4 Other National Markets 136

6 Competitive Landscape 137

  • 6.1 Overview of Key Vendors 137
  • 6.2 New Product Launch, Partnership, Investment, and M&A 143
  • 6.3 Company Profiles 144

Abbott Laboratories 144

    BIOTRONIK SE & Co. KG 146

      Boston Scientific Corporation 147

        Cochlear Limited 148

          electroCore, Inc. 149

            Inspire Medical Systems, Inc. 150

              LivaNova PLC 151

                Medtronic PLC 152

                  NeuroMetrix, Inc 153

                    Nevro Corp. 154

                      Nuvectra Corporation 155

                        OMRON CORPORATION 156

                          Pixium Vision 157

                            Second Sight Medical Products Inc 158

                              SetPoint Medical 159

                                Sonova Holding AG 160

                                  St. Jude Medical, Inc. 161

                                    Stimwave LLC 162

                                      7 Investing in Global Market: Risk Assessment and Management 163

                                      • 7.1 Risk Evaluation of Global Market 163
                                      • 7.2 Critical Success Factors (CSFs) 166

                                      Related Reports and Products 169

                                      Summary:
                                      Get latest Market Research Reports on Bioelectric Medicine. Industry analysis & Market Report on Bioelectric Medicine is a syndicated market report, published as Global Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Region: Trend Forecast and Growth Opportunity. It is complete Research Study and Industry Analysis of Bioelectric Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

                                      Last updated on

                                      REPORT YOU MIGHT BE INTERESTED

                                      Purchase this Report

                                      $3,280.00
                                      $4,400.00
                                      $5,600.00
                                      2,597.76
                                      3,484.80
                                      4,435.20
                                      3,030.72
                                      4,065.60
                                      5,174.40
                                      496,231.20
                                      665,676.00
                                      847,224.00
                                      273,453.60
                                      366,828.00
                                      466,872.00
                                      Credit card Logo

                                      Related Reports


                                      Reason to Buy

                                      Request for Sample of this report